Bosch Packaging Technology - Fully Automated Assembly of up to 70 Insulin Pens/Minute
At Achema, Bosch Packaging Technology showcased its latest version of the rotary pen assembly machine MRA. Developed by the Bosch subsidiary Moeller & Devicon, the machine is designed to assemble medical devices such as standard four-piece disposable pens or single-shot auto-injectors. These are used, for instance, for diabetes care, the treatment of autoimmune diseases, hormone replacement therapies or
emergency medicine. “We introduced the MRA to the market at last year’s Interpack in Germany. Since then, we have refined the technology by cooperating with several manufacturers of pens and auto-injectors, and have adapted the assembly processes for different models,” Michael Andersen, sales director at Moeller & Devicon, explained. “This way we can offer customers the appropriate machine with the required features according to the pens or autoinjectors in use.” Together with primary and secondary packaging solutions, the
new MRA can be combined to complete lines.
Four Pens at the Same Time
The MRA assembles the four components of each pen one step at a time: infeed systems load the pen caps, cartridge holders, cartridges and dosing mechanisms into the machine from four different in-feed stations, and fit them together to ready-to-use pens. The fully-automated machine handles four pens at the same time and achieves an output of up to 70 pens/minute. Incorrectly assembled products are automatically detected and rejected.
Thanks to its open construction, the platform offers a good overview of all stations and processes, ensuring easy operation and format settings. The automatic transportation and control stations between the different assembly steps reduce operator intervention and manual handling to a minimum. A Human Machine Interface (HMI) enables operators to monitor all process functions precisely. The compact design and small footprint fully comply with GMP and GAMP5.
Standard Upstream and Downstream Options
As an option, the MRA platform can be combined with additional upstream and downstream equipment. For instance, the liquid pharmaceuticals can be filled into cartridges and inspected for particles and cosmetic container defects on other Bosch equipment. “What customers ask for most are additional downstream solutions,” Michael Andersen explained. This includes labelling machines from Moeller & Devicon, which have been especially designed for pens and auto-injectors, as well as fully automated horizontal cartoning machines either from Bosch or third party suppliers, which can be combined to complete lines. An integration of downstream case packing and palletizing equipment is also possible.
“The flexible and modular design of the MRA platform enables an upgrade with further process steps, such as laser engraving of the pens or serialization,” Andersen underlined. Moreover, the platform can also be adapted for other medtec products, such as infusion sets, cannulas or catheters. The entire range of rotary pen assembly machines by Moeller & Devicon is complemented by manual, semi-automated and fully automated linear solutions for all customer requirements.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance